ITCI May 2024 25.000 call
| Previous close | 44.30 |
| Open | 44.30 |
| Bid | 42.20 |
| Ask | 47.00 |
| Strike | 25.00 |
| Expiry date | 2024-05-17 |
| Day's range | 44.30 - 44.30 |
| Contract range | N/A |
| Volume | |
| Open interest | 13 |
Simply Wall St.Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Intra-Cellular Therapies, Inc. ( NASDAQ:ITCI ) investors will be delighted, with the company turning in some strong...
Insider MonkeyIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript May 7, 2024 Intra-Cellular Therapies, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome to Intra-Cellular Therapies’ First Quarter 2024 Earnings Conference Call. At […]
GlobeNewswireIntra-Cellular Therapies to Participate in Two Upcoming Investor Conferences
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will participate in two upcoming investor conferences: 2024 RBC Capital Markets Global Healthcare ConferenceTuesday, May 14, 2024 at 10:00 a.m. ET in New York, NY Bank of America Healthcare Conference 2024Thursday, May 16, 2024 at 9:20 a.m. PT (12:2
